The opioid growth factor (OGF) and its receptor, OGFr, regulate proliferation in normal and cancer cells, and their expression has been shown to be downregulated in ovarian cancer [28,29] and to restrict proliferation in pancreatic cancer [30]. Here, PENK is linked to ovarian cancer.